NRx Pharma Submits ANDA For Preservative-free IV Ketamine
5/6 15:03
(RTTNews) - NRx Pharmaceuticals, Inc. (NRXP), Thursday said it has submitted Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for preservative-free IV ketamine formulation, NRX-100, for all approved uses such as anesthesia and pain managemen...